Suk Wai Lam

497 total citations
20 papers, 317 citations indexed

About

Suk Wai Lam is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oral Surgery. According to data from OpenAlex, Suk Wai Lam has authored 20 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 15 papers in Rheumatology and 6 papers in Oral Surgery. Recurrent topics in Suk Wai Lam's work include Sarcoma Diagnosis and Treatment (17 papers), Bone Tumor Diagnosis and Treatments (14 papers) and Oral and Maxillofacial Pathology (6 papers). Suk Wai Lam is often cited by papers focused on Sarcoma Diagnosis and Treatment (17 papers), Bone Tumor Diagnosis and Treatments (14 papers) and Oral and Maxillofacial Pathology (6 papers). Suk Wai Lam collaborates with scholars based in Netherlands, United States and Switzerland. Suk Wai Lam's co-authors include Judith V.M.G. Bovée, Károly Szuhai, Anne‐Marie Cleton-Jansen, Arjen H.G. Cleven, Tom van Wezel, Inge H. Briaire‐de Bruijn, Herman M. Kroon, Dina Ruano, Hans Morreau and Marie Kostine and has published in prestigious journals such as The American Journal of Surgical Pathology, European Journal of Cancer and The Journal of Pathology.

In The Last Decade

Suk Wai Lam

17 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suk Wai Lam Netherlands 11 216 147 76 64 54 20 317
Asle C. Hesla Sweden 9 200 0.9× 124 0.8× 72 0.9× 59 0.9× 33 0.6× 14 268
Friedl Sinnaeve Belgium 8 147 0.7× 102 0.7× 54 0.7× 54 0.8× 63 1.2× 17 260
Alison L. Cheah Australia 10 254 1.2× 169 1.1× 125 1.6× 46 0.7× 38 0.7× 20 348
Nathalie Stock France 9 211 1.0× 129 0.9× 82 1.1× 24 0.4× 48 0.9× 24 350
Emmanuel Khalifa France 7 163 0.8× 55 0.4× 112 1.5× 37 0.6× 55 1.0× 15 321
Elsa Arbajian Sweden 14 387 1.8× 280 1.9× 154 2.0× 54 0.8× 81 1.5× 19 525
Omar Jaber Jordan 9 143 0.7× 75 0.5× 73 1.0× 27 0.4× 78 1.4× 28 307
Esther Baranov United States 7 181 0.8× 128 0.9× 72 0.9× 21 0.3× 43 0.8× 17 270
Kesavan Sittampalam Singapore 9 215 1.0× 116 0.8× 129 1.7× 31 0.5× 40 0.7× 23 300
Ivy John United States 11 166 0.8× 160 1.1× 99 1.3× 20 0.3× 31 0.6× 38 306

Countries citing papers authored by Suk Wai Lam

Since Specialization
Citations

This map shows the geographic impact of Suk Wai Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suk Wai Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suk Wai Lam more than expected).

Fields of papers citing papers by Suk Wai Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suk Wai Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suk Wai Lam. The network helps show where Suk Wai Lam may publish in the future.

Co-authorship network of co-authors of Suk Wai Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Suk Wai Lam. A scholar is included among the top collaborators of Suk Wai Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suk Wai Lam. Suk Wai Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ong, Sheena L. M., Lioe‐Fee de Geus‐Oei, Hans Gelderblom, et al.. (2025). Neovascular prostate specific membrane antigen (PSMA) expression in bone and soft tissue sarcoma: a systematic analysis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(6). 1299–1309. 1 indexed citations
3.
Ijsselsteijn, Marieke E., Jessica Roelands, Suk Wai Lam, et al.. (2025). Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcoma. Cancer Immunology Immunotherapy. 74(8). 258–258. 1 indexed citations
4.
5.
Lam, Suk Wai, et al.. (2024). Sacrococcygeal chordoma with spontaneous regression due to a large hemorrhagic component. Skeletal Radiology. 54(1). 159–163. 2 indexed citations
6.
Krol, Augustinus D. G., Johan L. Bloem, Judith V.M.G. Bovée, et al.. (2024). Combining morphological and functional imaging parameters to diagnose primary bone neoplasms in the skull base, spine and sacrum. Skeletal Radiology. 54(2). 287–302.
7.
Lam, Suk Wai, et al.. (2023). Histological response to radiotherapy is an early event in myxoid liposarcoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(4). 487–495. 4 indexed citations
8.
Schrader, Anne M.R., Anne‐Marie Cleton-Jansen, Arnoud Boot, et al.. (2022). The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis. European Journal of Cancer. 173. 229–237. 23 indexed citations
9.
Lam, Suk Wai, Sushama Varma, Aihui Wang, et al.. (2022). GRM1 Immunohistochemistry Distinguishes Chondromyxoid Fibroma From its Histologic Mimics. The American Journal of Surgical Pathology. 46(10). 1407–1414. 14 indexed citations
10.
Lam, Suk Wai, et al.. (2022). New molecular entities of soft tissue and bone tumors. Current Opinion in Oncology. 34(4). 354–361. 9 indexed citations
11.
Lam, Suk Wai, Marie Kostine, Noel F.C.C. de Miranda, et al.. (2021). Mismatch repair deficiency is rare in bone and soft tissue tumors. Histopathology. 79(4). 509–520. 29 indexed citations
12.
Ong, Sheena L. M., Suk Wai Lam, Brendy E.W.M. van den Akker, et al.. (2021). Expanding the Spectrum of EWSR1-NFATC2-rearranged Benign Tumors. The American Journal of Surgical Pathology. 45(12). 1669–1681. 23 indexed citations
13.
Lam, Suk Wai, Inge H. Briaire‐de Bruijn, Tom van Wezel, et al.. (2021). NTRK fusions are extremely rare in bone tumours. Histopathology. 79(5). 880–885. 7 indexed citations
14.
Lam, Suk Wai, Arjen H.G. Cleven, Inge H. Briaire‐de Bruijn, et al.. (2021). FOS Rearrangement and Expression in Cementoblastoma. The American Journal of Surgical Pathology. 45(5). 690–693. 15 indexed citations
15.
Cornmark, Louise, Jakob Hofvander, Linda Magnusson, et al.. (2020). Loss of NF2 defines a genetic subgroup of non‐FOS‐rearranged osteoblastoma. The Journal of Pathology Clinical Research. 6(4). 231–237. 11 indexed citations
16.
Lam, Suk Wai, et al.. (2019). What’s new in bone forming tumours of the skeleton?. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(1). 147–157. 30 indexed citations
17.
Lam, Suk Wai, Arjen H.G. Cleven, Herman M. Kroon, et al.. (2019). Utility of FOS as diagnostic marker for osteoid osteoma and osteoblastoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(3). 455–463. 45 indexed citations
18.
Lam, Suk Wai, Kirsten van Langevelde, Albert J.H. Suurmeijer, Arjen H.G. Cleven, & Judith V.M.G. Bovée. (2019). Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis. Histopathology. 75(6). 843–852. 10 indexed citations
19.
Lam, Suk Wai, Anne‐Marie Cleton-Jansen, Arjen H.G. Cleven, et al.. (2018). Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR–Based Targeted Next-Generation Sequencing. Journal of Molecular Diagnostics. 20(5). 653–663. 79 indexed citations
20.
Lam, Suk Wai, David G.P. van IJzendoorn, Anne‐Marie Cleton-Jansen, Károly Szuhai, & Judith V.M.G. Bovée. (2018). Molecular Pathology of Bone Tumors. Journal of Molecular Diagnostics. 21(2). 171–182. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asle C. Hesla Breakdown of academic impact, for papers by Friedl Sinnaeve Breakdown of academic impact, for papers by Alison L. Cheah Breakdown of academic impact, for papers by Nathalie Stock Breakdown of academic impact, for papers by Emmanuel Khalifa Breakdown of academic impact, for papers by Elsa Arbajian Breakdown of academic impact, for papers by Omar Jaber Breakdown of academic impact, for papers by Esther Baranov Breakdown of academic impact, for papers by Kesavan Sittampalam Breakdown of academic impact, for papers by Ivy John
Rankless by CCL
2026